Citation Impact

Citing Papers

Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Molecular Cloning and Characterization of an Aquaporin cDNA from Salivary, Lacrimal, and Respiratory Tissues
1995 StandoutNobel
Myeloproliferative disorders: complications, survival and causes of death
2000
Chronic Myelomonocytic Leukemia: Natural History and Prognostic Determinants
1989
Point of View: Chronic Myelomonocytic Leukaemia (CMML)–A Myelodysplastic or Myeloproliferative Syndrome?
1993
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia.
1994 StandoutNobel
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
2007
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
2012
Aquaporin water channels: molecular mechanisms for human diseases1
2003 StandoutNobel
Aquaporin Water Channels in Kidney
2000 StandoutNobel
Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors
1990
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
1996 Standout
Membrane Dynamics of the Water Transport Protein Aquaporin-1 in Intact Human Red Cells
1999 StandoutNobel
The aquaporin family of water channels in kidney
1995 StandoutNobel
Functional Analysis of Aquaporin-1 Deficient Red Cells
1996 StandoutNobel
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Targeting multidrug resistance in cancer
2006 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
2006
Defective Urinary Concentrating Ability Due to a Complete Deficiency of Aquaporin-1
2001 StandoutNobel
Epstein–Barr virus: 40 years on
2004 Standout
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
2001
Aquaporin water channels: unanswered questions and unresolved controversies
1995 StandoutNobel
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface
2007
Aquaporin water channels – from atomic structure to clinical medicine
2002 StandoutNobel
Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens.
1994 StandoutNobel
The Human Aquaporin-5 Gene
1996 StandoutNobel
2 The histopathology of chronic myeloproliferative diseases
1998
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
1999
Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia
1988
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Mitoxantrone
1996
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
2002
The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain.
1996 StandoutNobel
Mutations in aquaporin-1 in Phenotypically Normal Humans Without Functional CHIP Water Channels
1994 StandoutScienceNobel
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder?A prospective multicenter study of 100 patients
1991
Allogeneic Marrow Transplantation in the Treatment of Preleukemia
1984
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.
1996
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease
1999
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Primary Myelofibrosis: Update on Definition, Pathogenesis, and Treatment
2008
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study
1996
The Clonal Evolution of Tumor Cell Populations
1976 StandoutScience
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
Aqp1 expression in erythroleukemia cells: genetic regulation of glucocorticoid and chemical induction
1997 StandoutNobel
Molecular Characterization of Novel Reciprocal Translocation t(6;14) in an Epstein-Barr Virus-Transformed B Cell Precursor
1987 StandoutNobel
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
Decreased pulmonary vascular permeability in aquaporin-1-null humans
2002 StandoutNobel
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b- ), Co(a-b-)]
1994
Polycythemia vera: myths, mechanisms, and management
2002
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.
1996 StandoutNobel
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Cellular and Molecular Biology of the Aquaporin Water Channels
1999 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases
1987
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia
1994
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
2007
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2008
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
2007
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia
1999 StandoutNobel

Works of C Bernasconi being referenced

A prospective comparison of α-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients
1992
Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy
1994
Mitoxantrone for refractory and relapsed acute leukemia
1990
Interferon alpha‐2b as treatment for Philadelphia‐negative chronic myeloproliferative disorders with excessive thrombocytosis
1989
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
2003
Induction of Ethinylestradiol and Levonorgestrel Metabolism by Oxcarbazepine in Healthy Women
1999
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients
1990
Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance
1986
Transposition of 9q34 and 22 (q11?qter) regions has a specific role in chronic myelocytic leukemia
1979
Pathogenetic significance of ?pure? monosomy 7 in myeloproliferative disorders. analysis of 14 cases
1982
Chronic myelomonocytic leukemia: Clinical features, cytogenetics, and prognosis in 30 consecutive cases
1985
Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients
1989
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies
2000
Rankless by CCL
2026